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Abstract 
Food insecurity poses a significant socio-economic problem in third world economies, 
particularly in countries that rely heavily on maize and maize products. Ubiquitous soil 
fungi parasitize agricultural commodities and produce mycotoxins. Fumonisin B2 (FB2), 
a neglected mycotoxin, is produced by several Fusarium species. The aim of this study 
was to investigate mitochondrial stress responses in human embryonic kidney 
(Hek293) cells exposed to FB2 for 24 hours (hr). Cell viability was assessed via the 
methylthiazol tetrazolium (MTT) assay and the half maximal inhibitory concentration 
(IC50) value (317.4 µM) was generated. Additional concentrations of 100 µM and        
500 µM were selected to achieve a broader toxic profile of FB2. Reactive oxygen 
species (ROS) was quantified (fluorescence), mitochondrial membrane depolarisation 
(fluorescence) was assessed and adenosine triphosphate (ATP) concentration was 
evaluated (luminometry) to assess mitochondrial integrity. The relative expression of 
mitochondrial stress response proteins, Sirtuin 3 (SIRT3), Nuclear factor (erythroid-
derived 2)-like 2 (Nrf2), LON protease (LONP1), PTEN-induced putative kinase 1 
(PINK1), ubiquitin-binding adaptor p62 (p62) and heat shock protein 60 (HSP60) was 
determined by western blots. Transcript levels of SIRT3, PINK1 and microRNA-27b 
(miR-27b) was assessed using quantitative PCR (qPCR). Results indicated that both 
low and high concentrations of FB2 that were within the naturally occurring 
concentration range of the compound were able to induce mitochondrial dysfunction. 
FB2 (IC50) downregulated mitochondrial stress proteins and upregulated mitophagy 
markers. Despite upregulation of mitochondrial stress maintenance proteins at the 
highest concentration (500 µM) of FB2, mitophagic markers increased with subsequent 
cell death; whilst at a lower concentration (100 µM) of FB2, mitochondrial stress protein 
expressions were upregulated resulting in decreased expression of mitophagic 
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markers and cell proliferation. In conclusion, FB2 was cytotoxic to the kidney derived 
Hek293 cells via induction of mitochondrial stress and mitophagy.  
Keywords: Fumonisin B2, mitophagy, mitochondrial stress, PINK1, Nrf2, SIRT3, 
human kidney cells, microRNA 
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Chapter 1: Introduction 
1.1 Background 
Extreme weather conditions cause ubiquitous soil fungi to parasitize agricultural 
commodities and produce mycotoxins (Hussein and Brasel, 2001). Mycotoxins are 
beneficial to fungi as they are toxic to other organisms, and are considered as a fungal 
survival mechanism (Hussein and Brasel, 2001). 
FB2 is a highly prevalent mycotoxin produced mainly by Fusarium verticillioides, a 
common contaminant of maize (Stockmann-Juvala and Savolainen, 2008). The World 
Health Organisation (WHO) has reported that industrial countries have low exposure 
to the toxin however, exposure often exceeds the provisional maximum tolerable 
intake of 2 µg/kg in developing countries such as South Africa, Nigeria, Malawi and 
China with daily exposure exceeding 15 µg/kg body weight (Shephard et al., 2007). 
Despite the high prevalence of FB2, there is a dearth of toxicity studies on FB2 in 
comparison to its structural analogue Fumonisin B1 (FB1) which has been extensively 
studied. FB1 has been implicated in diseases such as equine leukoencephalomalacia 
(ELEM), pulmonary oedema, neural tube defects and oesophageal cancer in humans. 
The toxin exerts its noxious effects in humans via numerous pathways including 
induction of apoptosis, oxidative stress and epigenetic changes (Stockmann-Juvala et 
al., 2004, Chuturgoon et al., 2014). The mechanisms of FB2  toxicity however, remains 
elusive despite FB2 showing greater cytotoxic potential than FB1 (Riley et al., 1997).  
FB2 has a higher polarity than FB1 due to the presence of an additional hydroxyl group. 
This allows for FB2 to be rapidly excreted via kidney as it is highly water soluble, 
causing the kidney to be susceptible to FB2 –induced toxicity. The amino group of FB2 
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allows it to utilise endogenous amino acid transporters to cross cell membranes and 
therefore interact with cellular structures resulting in cellular dysfunction and cell death 
(Stockmann-Juvala and Savolainen, 2008). Previous studies, using equine cells, have 
demonstrated the ability of FB2 to inhibit de novo sphingolipid biosynthesis however, 
no data to date exists on its physiological and biochemical effects in humans (Riley et 
al., 1997).  
Studies have shown the ability of some mycotoxins to upregulate mitochondrial stress 
in cells however, limited evidence is available to demonstrate the effects of fumonisins 
on mitochondria (Domijan and Abramov, 2011, Arumugam et al., 2019). Mitochondrial 
function is imperative to overall cell health and loss of function results in many adverse 
effects including decreased ATP concentrations, increased oxidative stress and 
apoptosis or necrosis (Picard et al., 2011b). Upon exposure to toxins the mitochondria 
activate antioxidant and mitochondrial stress responses (Youle and Narendra, 2011). 
Proteins such as SIRT3 and LONP1 are activated in an attempt to maintain 
mitochondrial function. Activation of such proteins can directly ameliorate 
mitochondrial stress or result in the upregulation in the expression of other proteins 
that can reduce stress (Ngo and Davies, 2007, Bause and Haigis, 2013). 
Failure to do so results in mitophagy, i.e., degradation of the mitochondria mediated 
by the proteins PINK1 and p62 (Youle and Narendra, 2011). This process is further 
regulated by a group of small non-coding RNA’s namely micro-RNAs (miRNA). 
Specifically, the upregulation of miR-27b expression leads to a suppression of PINK1 
expression at a translation level directly through binding to the 3′-untranslated region 
(3′-UTR) of its messenger RNA (mRNA), thus inhibiting the occurrence of mitophagy 
within cells. Conversely, the inhibition of miR-27b expression promotes mitophagy in 
cells (Kim et al., 2016). Additionally, transcription factors normally involved in stress 
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responses associated with the mitochondria such as Nrf2, allows for the transcriptional 
activation of PINK1 in an attempt to promote mitophagy. The subsequent removal of 
damaged mitochondria has been shown to encourage cell survival by reduction of 
overall stress on cellular processes (Murata et al., 2015). 
The mechanisms of FB2-induced mitochondrial stress responses in kidney cells 
remains unknown. Thus the purpose of this study was to determine the effects of FB2 
on the mitochondrial stress responses in Hek293 cells by determining mitochondrial 
output and dysregulation of mitochondrial maintenance following exposure. 
1.2 Problem statement 
FB2 has been found to commonly contaminate maize which is the staple diet in South 
African and many other third world countries. Contamination of crop poses a serious 
threat to consumers’ health and increases food insecurity. Little is known about the 
effect of FB2 on humans as opposed to FB1 despite the toxin potentially being more 
cytotoxic and co-produced. Although the toxin has been implicated in sphingolipid 
metabolism inhibition, the biochemical pathways surrounding its human toxicity are 
yet to be elucidated. Furthermore, no data exists to show the toxicity of FB2 in kidney 
cells. This is essential as FB2 has a high polarity causing it to be excreted rapidly by 
kidneys permitting toxic interactions. Additionally, FB2 is excreted unmetabolised via 
the kidney increasing the kidneys susceptibility to toxicity. 
1.3 Research questions 
The study focussed on looking at the mitochondrial toxicity induced by FB2 in a kidney 
cell line. The kidney is particularly susceptible to the toxic effects of FB2 due to the high 
polarity of the toxin thus increasing retention time of the unmetabolised compound. 
Additionally, the kidney is densely populated with mitochondria which increases the 
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risk of mitochondrial toxicity occurring. The following research questions were 
proposed: 
 Does FB2 interfere with kidney cell mitochondrial output? 
 Does FB2 induce mitochondrial stress in kidney cells? 
 Doe FB2 induce mitophagy in kidney cell? 
1.5 Aims and Objectives 
1.5.1 Aim of study 
The aim of this study was to determine the mechanism of mitochondrial toxicity of FB2 
in Hek293 by investigating its role on mitochondrial stress response proteins and 
mitophagy bio-markers. 
1.5.2 Objectives 
 To determine the mitochondrial output following FB2 exposure 
 To determine the biochemical mechanism of mitochondrial stress induction and 
mitophagy by FB2 
1.6 Hypothesis 
FB2 induces human kidney toxicity via upregulation of mitochondrial stress and 
induction of mitophagy within kidney cells. 
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Chapter 2: Literature Review 
2.1 Mycotoxins 
Mycotoxins are secondary metabolites that are primarily produced by the mycelial 
structure of filamentous fungi bearing no major biochemical importance to the growth 
of the fungi. The term originates from Greek words meaning fungus (mykes) and 
poison (toxicum) (Goldblatt, 1972). These metabolites are produced when moulds 
release enzymes that degrade macromolecules for growth and metabolism. In doing 
so they gain the ability to absorb low molecular weight nutrients and produce 
secondary metabolites (mycotoxins). These have no effect on primary metabolism 
however, they may possess biological activity and be toxic to other organisms (Moss, 
1991) 
Tropical climates with high temperatures, increased humidity and rainfall promote 
fungal growth and mycotoxin formation (Bhat and Vasanthi, 2003). Thus, the 
production of mycotoxins is promoted by both favourable ecological conditions and 
storage environments (Hussein and Brasel, 2001). Mycotoxins account for detrimental 
loss in global wealth due to contamination of agricultural commodities. Therefore, they 
hold great significance in the public health and agro-economic sector due to adverse 
effects elicited upon exposure. The Food and Agriculture Organisation has estimated 
that roughly 25% of condemned agricultural products are contaminated with 
mycotoxins (Boutrif and Canet, 1998). The most studied groups of contaminants 
include with aflatoxins, ochratoxins and fumonisins (Heidtmann-Bemvenuti et al., 
2011).                                                                                                                                                                                                                                                                                                                                                                                                                  
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2.1.1 Mycotoxin history 
Mycotoxicoses refers to acute diseases induced by mycotoxins in animals and 
humans (Hoerr, 2020). This phenomenon was noted for several years however, in 
England in 1960, the outbreak of Turkey X disease led to the discovery of aflatoxins. 
Furthermore, it was discovered that minute doses of secondary metabolites in 
consumables can induce disease (Ostry et al., 2017). This led to an increase in studies 
revolving around mycotoxins and its toxic effects. Several mycotoxins existing today 
were initially proposed as potential antibiotics but were later disregarded due to their 
high toxicity (Alshannaq and Yu, 2017). 
2.1.2 Implications to food safety and health 
Mycotoxins can cause both direct and indirect contamination. Direct contamination 
refers to growth of moulds on food itself. This may occur during production of 
consumables during storage or transportation. The contaminated food is consumed 
resulting in direct exposure. Although this seems unlikely, in areas with food shortages 
consumers are forced to ingest contaminated foods to prevent starvation. In other 
areas mould consumption is common due to it always being present such as in areas 
with tropical climates whereas many countries use fungi in production of food. 
Commercial use of mould has been proved to be non-mycotic and safe however, home 
fermentation is unreliable and potentially hazardous (Alshannaq and Yu, 2017). 
Indirect consumption occurs when a contaminated food ingredient is used for 
production and is less frequent than direct exposure. This is more prevalent in food 
manufacturing or processing. Additionally, it may arise when animal products 
containing mycotoxin residues are consumed and is more common in developed 
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countries such as America, European states and Canada (Hesseltine et al., 1966, 
Alshannaq and Yu, 2017) 
The most notorious food borne mycotoxins include aflatoxins, ochratoxins and 
fumonisins. Aflatoxin has been classified as a class I carcinogen by the International 
Agency for Research on Cancer (IARC) (IARC, 2002). They have the ability to induce 
stunted growth if exposure prior to birth or during early childhood development occurs. 
The toxin suppresses cell-mediated immune responses posing huge threats to human 
health (Pitt, 2013).  
Ochratoxin A induces chronic nephrotoxicity compromising kidney function in both 
humans and animals. The carcinogenic mechanism remains elusive with its outcomes 
being less potent than its kidney toxicity with both genomic and non-genomic modes 
of action (Pitt, 2013).  
Previously mycotoxin contamination in Africa was often overlooked due to ignorance 
regarding its existence and implications in health safety. In more recent times, the 
Fusarium and Aspergillus genera have received special attention as they are 
considered to be the most hazardous to health in Africa (WHO, 2006). Fumonisins 
demonstrate several of adverse effects. Most commonly they induces ELEM in horses 
and pulmonary oedema in pigs. Studies in humans link exposure to oesophageal 
cancer especially in South Africa where maize consumption is high (Pitt, 2013). 
2.2 Fumonisin 
Fumonisins are mycotoxins produced by the Fusarium species amongst others. The 
mycotoxin was first discovered in South Africa in 1988 (Marasas et al., 1988, Marasas, 
2001). They are frequently found as contaminants in maize and maize-based products 
(Shephard et al., 1996). Previously, data had only showed the occurrence of 
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fumonisins in maize however, most recently, it was found in garlic bulbs (Seefelder et 
al., 2002), onion powder (Boonzaaijer et al., 2008), peanuts (Liu et al., 2008) and 
soybeans (Aoyama et al., 2010).  In South Africa detection of the toxin in dietary and 
medicinal wild plants (Sewram et al., 2006) has been documented. Fumonisin B1 and 
B2 are the most prevalent and contribute to 70% of fumonisin abundance (Seo et al., 
2001). 
2.2.1 Fumonisin general structure and toxicity 
In comparison to other mycotoxins, fumonisins have long hydroxylate hydrocarbon 
chains without cyclic structures. FB1 is the diester of propan-1,2,3 tricarboxylic acid 
and 2-amino-12,16-dimethyl 3,5,10,14,15-pentahroxyeicosane in which C14 and C15 
hydroxyl groups are esterified with the terminal carboxyl group or tricarboxylic acid. R-
groups refer to different side chains present on different types of fumonisins (Figure. 
2.1). FB2 is the C10 deoxy analogue of FB1 in which the corresponding stereogenic 
units of the eicosane backbone have the same configurations (Desjardins and Proctor, 
2007).  
 
Figure 2.1: General structure of the fumonisin mycotoxin (Gelderblom et al., 1993) 
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Fumonisins have a structure very close to that of the free sphingoid base sphinganine 
and sphingosine (Figure 2.2).  
 
Figure 2.2: Comparison of fumonisin structures, sphinganine and sphingosine 
(prepared by author) 
Therefore, it was concluded that fumonisins exert their toxicity via disrupting 
sphingolipid metabolism and inhibiting sphingolipid function. Sphingolipids hold 
essential roles in membrane and lipoprotein structure, cell-cell communications and 
as secondary messengers (Soriano et al., 2005). 
Disruption of sphingolipid metabolism results in a series of events alluding to altered 
cell growth, in both in vivo and in vitro models. This causes growth inhibition, and both 
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apoptotic and oncotic cell death in liver and kidneys. Aside from this mechanism of 
toxicity the mycotoxin can induce oxidative stress initiating a cascade of adverse 
effects (Theumer et al., 2010). 
The highly studied FB1 has been implicated as a causative agent in various 
pathologies affecting farm animals. Furthermore, studies demonstrated the 
hepatotoxic and carcinogenic effects of the toxin. Research involving humans 
associate the toxin with oesophageal cancer and neural tube defects more specifically 
in the Transkei (Marasas, 2001, Missmer et al., 2005). Recent toxicology studies 
demonstrate the ability of FB1 to induce various adverse effects in humans however, 
it was established that hydrolysed FB1 was less toxic compared to its counterpart 
(Voss et al., 2009). Additionally, FB1 has the ability to cross the blood brain barrier 
inducing neurotoxic effects in young carp (Kovačić et al., 2009). Studies surrounding 
the toxicity of FB2 are limited however, it has been implicated in neurotoxicity in horses 
(Thiel et al., 1991).  
2.2.2 Fumonisin detoxification 
Cholestyramine, a bile acid sequestrant was shown in both in vivo and in vitro models 
to effectively bind both FB1 and FB2 (Avantaggiato et al., 2005). Enzymatic 
detoxification processes use recombinant enzymes (carboxylesterase) from bacteria 
to hydrolyse fumonisins resulting in the loss of tricarboxylic groups. This is followed by 
deamination processes in the presence of pyruvate and pyridoxal phosphate (Heinl et 
al., 2010). Lactic acid has been shown to bind FB1 and FB2 via use of peptoglycan 
binding sites. FB2 is more bound than FB1 with a minimum of one tricarboxylic acid 
moiety involved in binding (Niderkorn et al., 2009). 
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2.3 Fumonisin B2 
Initially Fusarium species were thought to be the only producers of FB2 however, more 
recent studies have shown the production of the toxin by Aspergillus niger isolated 
from coffee and grapes. Additionally, the toxin has been detected in wine and beer 
contamination thus increasing the list of food commodities affected by fumonisin 
exposure other than maize (Scott, 2012). FB2 has been classed as a type 2B 
carcinogen by IARC (IARC, 2002). Previous studies have showed that the toxin has 
similar cancer initiating properties as FB1 however, comparative cytotoxic test showed 
that FB2 is more toxic than FB1 in rat hepatocytes (Gelderblom et al., 1993, Shephard 
et al., 1996). This was confirmed by FB2 being able to reduce the body weight of rats 
by a greater percentage than other fumonisin subtypes which was attributed to its 
ability to disrupt sphingolipid metabolism (Gelderblom et al., 1993, Shephard et al., 
1996).   
FB2 is the C10 deoxy analogue of FB1 in which the corresponding stereogenic units of 
the eicosane backbone have the same configurations. The amino group present on 
the hydrocarbon chain has been implicated in the mechanism of toxicity of the 
compound (Figure 2.3) (Desjardins and Proctor, 2007). 
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Figure 2.3: Structure of FB2 (Carrasco-Sánchez et al., 2017) 
FB2 has demonstrated to be excreted unmetabolised through urine, bile and faeces 
(Shephard et al., 1995). The amino group of FB2 has been shown to play a major role 
in the toxicity of the compound as endogenous systems are able to recognise the 
group and mistaken FB2 for native structures. This allows FB2 to bind to enzymes and 
complexes in cells resulting in competitive inhibition (Gelderblom et al., 1993, Soriano 
et al., 2005). The structure of FB2 remains intact during excretion as it is 
unmetabolised. This enhances its toxicity as the amino group is able to interact with 
cellular entities. Furthermore, the high polarity of FB2 increases its water solubility 
causing it to be excreted at a faster rate than other fumonisin subtypes (Gelderblom 
et al., 1993). This increases the susceptibility of excretory organs such as the kidney 
as the compound is not structurally modified and excretion via the kidney permits toxic 
interactions with cellular structures. 
The most common noted side effect of FB2 exposure is observed in horses largely 
annotated to its interference with sphingolipid metabolism (Thiel et al., 1991). Aside 
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from this the toxin has exhibited phytotoxicity when introduced to maize and tomato 
seedlings through its ability to activate pathogen infection induced hypersensitive 
responses (Lamprecht et al., 1994, Saucedo-García et al., 2011). 
2.3.1 Fumonisin B2 mechanism of action 
FB2 is responsible for the inhibition of de novo sphingolipid biosynthesis (Figure 2.4). 
 
Figure 2.4: Mechanism of action of FB2 (Voss et al., 2007) 
They act as competitive inhibitors for the substrate of ceramide synthase which is 
essential for the transfer of fatty acids from fatty acyl –COA’s to sphinganine and 
sphingomyelin (Enongene et al., 2000, Soriano et al., 2005).  The structural similarity 
of FB2 and sphinganine allows ceramide synthase to recognise the toxin as a 
substrate. More specifically the amino group of FB2 binds to ceramide synthase 
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causing inhibition of the enzymes activity (Gelderblom et al., 1993, Enongene et al., 
2000). 
The inhibition of ceramide synthase prevents the incorporation of serine into the 
backbone of dihydroceramides and complex sphingolipids. Furthermore, FB2 inhibits 
the conversion of sphinganine to sphingosine via acylation which adds a double bond 
to the substrate. In healthy functioning cells, reacylation of sphingosine occurs, which 
is released during hydrolysis of complex sphingolipids however, this is prevented when 
FB2 is introduced. Ultimately, this initiates the accumulation of sphinganine in cells and 
promotes formation of sphinganine 1-phosphate and sphingosine 1-phosphate with 
simultaneous cleavage of the sphingoid backbone to produce fatty aldehydes and 
ethanolamine 1-phosphate (Merrill Jr et al., 2001). 
Increased concentrations of sphingoid bases is known to inhibit the activity of protein 
kinase C and increase protease activity. Inhibition of protein kinase C is associated 
with elevated susceptibility to apoptosis (Merrill et al., 1993, Spiegel and Merrill Jr, 
1996). Sphingosine accumulations affect insulin receptor tyrosine active (Arnold and 
Newton, 1996), calmodulin-dependent kinase activity (Jefferson and Schulman, 1988) 
and tyrosine kinases of epidermal growth factor receptors (Davis et al., 1988). 
Furthermore, sphingosine causes dephosphorylation of retinoblastoma protein thus 
inducing growth inhibition. Concentration of sphingosine 1- phosphate in cells has 
been shown to induce the release of calcium, thus causing perturbations in calcium 
homeostasis (Olivera et al., 1994). 
2.4 Mitochondria 
The mitochondria are commonly highlighted as energy sources of cells leading to 
classification of the organelle as an essential but independent functional subunit in 
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cells (Wallace and Starkov, 2000). Early research described mitochondrion as the 
location for the production of ATP via breakdown of fatty acids and sugars, oxidative 
phosphorylation (OXPHOS) and the citric acid cycle (Figure 2.5). Additional functions 
include lipid and steroid metabolism, DNA replication/transcription and protein 
translation. Furthermore, mitochondrial function plays a vital role in cell cycle 
regulation and differentiation. However, studies have focused on dynamic 
mitochondrial pathways including fission, fusion and motility events which are closely 
regulated by mitochondrial proteins (McBride et al., 2006). 
 
 
 
 
 
 
 
 
Figure 2.5: Structure and selective functions of mitochondria (prepared by author) 
The unusual double membrane of mitochondria separates the organelle into four areas 
namely the outer membrane, intermembrane space, inner membrane and matrix. The 
citric acid cycle occurs within the matrix. The inner membrane is strategically folded 
into cristae to increase the surface area of the organelle (Figure. 2.5). This area 
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contains complexes that are required for the electron transport chain  (ETC)  and thus 
being a controller of the rate of cell metabolism (Figure. 2.5) (McBride et al., 2006). 
Aside from the common production of ATP, the mitochondria are responsible for the 
endogenous production of ROS. This is essential for cell survival as ROS acts as redox 
messengers thus mediating intracellular signalling pathways. The majority of ROS 
production within the mitochondria occurs during the ETC and disruptions in the 
process leads to unwarranted ROS production leading to states of oxidative stress 
(Kowaltowski and Vercesi, 1999). Additionally, the mitochondria is the site for the 
intrinsic apoptotic pathway which is programmed cell death induced by caspases 
(proteins) within the organelle (Mayer and Oberbauer, 2003). Due to mitochondria 
being the prime location for several crucial processes, any irregularities pose a major 
threat to overall cell function and health.  
2.4.2 Mitochondrial Toxicity 
Essential mitochondrial pathways play an important role in maintaining overall cell 
homeostasis. Several xenobiotics have been shown to selectively target the 
mitochondria causing dysregulation in processes and inducing mitochondrial toxicity 
as a mechanism of action (Liu and Wang, 2016, Tsai et al., 2016). Due to the 
mitochondria being a target for toxicity, mitochondrial dysfunction has been implicated 
in several pathologies including Alzheimer’s disease, Parkinson’s disease, 
cardiomyopathy, cancer and diabetes (King et al., 2006, Duncan, 2011, Exner et al., 
2012, Wang et al., 2014).  
The most prominent consequence of mitochondrial dysfunction is reduced energy 
production. However, notably increases in mitochondrial catalysed side reactions 
occur during dysfunction. These include free radical production and exothermic 
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combustion of oxygen, which result in cellular damage (Wallace and Starkov, 2000). 
Primary toxicity may arise when inhibition of the respiratory chain ATP synthase and 
uncoupling of OXPHOS occurs. Secondary mitochondrial toxicity refers to interference 
with mitochondrial biogenesis, protein synthesis, gene expression and inhibition of 
membrane transporters (Zoll et al., 2003, Picard et al., 2011a). 
The most common mechanism of mitochondrial toxicity is interference with the ETC 
resulting in exacerbated ROS production. The imbalance of ROS and antioxidants 
within cells leads to oxidative stress. ROS has the ability to interact with 
macromolecules such as proteins and lipids causing conformational changes, which 
further induce stress (Kowaltowski and Vercesi, 1999). The inability to ameliorate 
oxidative stress induces cell death. In other cases, manipulation in mitochondrial 
apoptotic pathways induces uncontrolled cell death which has been commonly 
observed in several cancers (Reed, 1999). 
2.4.3 Mycotoxins and Mitochondrial toxicity 
A multitude of studies have been carried out testing the effects of mycotoxins on 
cellular function with specificity to mitochondrial function. Studies have revealed the 
ability of certain mycotoxins to induce potent toxicity via inhibition of state 3 of 
mitochondrial respiration as well as inducing uncoupling effects (Kawai et al., 1983). 
Furthermore, a study using a Fusarium mycotoxin (Fusaric acid) illustrated abilities to 
induce lipid peroxidation and upregulation in mitochondrial stress mechanisms. In the 
same study aberrant mitochondrial biogenesis and upregulations in apoptosis was 
noted (Abdul et al., 2016). Other mycotoxins such as trichothecenes induce mitophagy 
as an adaptive response to toxicity thus reducing mycotoxin induced oxidative stress 
with inhibition in protein synthesis noted (Umer and Anwar, 2014). An unusual 
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mechanism of mitotoxicity is that of FB1 which deregulates calcium homeostasis and 
inhibits mitochondrial respiration via inhibition of complex I of the respiratory chain. 
This leads to increased mitochondrial membrane depolarisation, increased ROS 
production and interruption in calcium signalling hampering overall cell functionality 
(Domijan and Abramov, 2011). 
2.5 Mitochondrial Stress Responses 
In order to maintain mitochondrial integrity, the mitochondria has several mechanisms 
to combat deviations that may arise due to toxicity or endogenous irregularities. This 
is imperative to the overall functioning of cells and aids in reducing stress within the 
mitochondria (Wallace and Starkov, 2000). 
The mitochondria have been shown to release peptides to mediate stress responses. 
A key example is the mitochondrial unfolded protein response (UPRmt) which is 
initiated by a collection of unfolded proteins in the mitochondria (Benedetti et al., 2006, 
Hill et al., 2018). During this response misfolded proteins induce an increase in ATP 
production to aid in the cleavage of misfolded proteins as certain mediators are ATP-
dependent. The organelle has dedicated a multitude of molecular chaperones and 
enzymes to ensure correct folding of proteins with a set of quality control enzymes to 
degrade misfolded proteins (Pellegrino et al., 2013). The tightly regulated process is 
disturbed by the ETC generation of ROS and mitochondrial DNA vulnerabilities to 
damage. The UPRmt is a mitochondrial to nuclear signalling pathway that allows for 
the transcription of mitochondrial stress genes and chaperones to maintain 
homeostasis (Benedetti et al., 2006). 
Furthermore, the mitochondria is able to mediate redox signalling through the 
endogenous production of ROS. ROS are required for the adequate functioning of 
21 
 
cells such as the production of ATP in the mitochondria and for oxygen-dependent 
killing however, excess amounts of ROS (oxidative stress) may result in damage to 
DNA, proteins, lipids and disruption of cellular processes. Due to the mitochondria 
producing most of the cellular ROS, oxidative insult within the organelle occurs at a 
higher rate. Therefore, the mitochondria have mechanisms to reduce oxidative stress 
within the cell via the antioxidant defence system (Wallace and Starkov, 2000). 
Programmed cell death within the mitochondria is initiated by mitochondrial caspases 
and occurs in order to prevent the spread of stress and dysfunction to other cells. The 
process results in the release of pro-apoptotic proteins such as cytochrome c which 
aid in cell death. The most common trigger of the intrinsic apoptotic pathway is a loss 
in mitochondrial membrane potential that generally occurs during mitochondrial 
dysfunction. This is a tightly regulated process and is vital to ensure the health of the 
organism (Mayer and Oberbauer, 2003). 
2.5.1 Proteins involved in mitochondrial stress responses 
2.5.1.1 Sirtuins 
Sirtuins (SIRT) are nicotinamide adenine dinucleotide (NAD+) dependent proteins that 
belong to a family of deacetylase enzymes with SIRT1-7 being present in humans. 
Primarily, they function to remove an acetyl group from the amino group of a lysine 
residue thus activating or inhibiting the protein (David Adams and Klaidman, 2007). 
More specifically, sirtuins deacetylate proteins and transcription factors involved in the 
regulation of stress, metabolism, survival and aging. Human SIRT (SIRT1-7 ) share a 
conserved Sir2 catalytic core however, they have variable amino and carboxy terminal 
extensions, which provide uniqueness in location and catalytic function (Huang et al., 
2010). 
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2.5.1.2 Sirtuin 3  
Sirtuin 3 (SIRT3) is located in the mitochondrial matrix and is responsible for the 
activation or inhibition of several proteins. SIRT3 is able to induce post translational 
modifications to proteins thus regulating their activity. The post translation 
modifications may increase the activity of the protein or cause suppression of activity. 
In doing so, SIRT3 has been described as a modulator of several pathways through 
its deacetylating effects on essential enzymes and proteins (Figure 2.6) (Bause and 
Haigis, 2013). 
SIRT3 has been shown to target enzymes in the citric acid cycle namely isocitrate 
dehydrogenase 2 and aconitase and therefore indirectly regulates respiration. 
Furthermore, activation of SIRT3 has proven to increase OXPHOS with coinciding 
increases in deacetylation of enzymes in complex I and II of the ETC further verifying 
its regulation of respiration (Ahn et al., 2008, Cimen et al., 2009, Bao et al., 2010).  
Aside from metabolic regulation, SIRT3 is important for the regulation of mitochondrial 
ROS production. At substrate level manganese superoxide dismutase (mnSOD), 
which is responsible for ROS scavenging is deacetylated and activated by SIRT3, thus 
reducing oxidative stress. Similarly SIRT3, deacetylates forkhead box O3 (FOXO3a) 
(involved in antioxidant responses), aiding in its translocation to the nucleus (Kim et 
al., 2010). SIRT3 has a high affinity for FOXO transcription factors during oxidative 
stress in an attempt to upregulate antioxidant systems. Indirect regulation includes the 
activation of isocitrate dehydrogenase, which increases nicotinamide adenine 
dinucleotide (NADH) concentration, thus facilitating the production of reduced 
glutathione (antioxidant) (Someya et al., 2010). 
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Studies have shown that SIRT3 protein and gene expression is significantly elevated 
in states of mitochondrial stress. Inhibition of SIRT3 has prevented amelioration of 
mitochondrial stress and led to cell death. The expression of the enzyme is dependent 
on the degree of stress present where increases in stress coincides with upregulation 
in SIRT3 expression (Weir et al., 2013). In similar studies it was observed that SIRT3 
deacetylates and inhibits mitochondrial Ribosomal protein L10 which causes 
suppression of mitochondrial protein synthesis as a possible energy conservation 
method during stress (Yang et al., 2010). 
Notably, SIRT3 aids in detoxification of ammonia during amino acid metabolism via 
activation of orthinine transcarbamoylase (Hallows et al., 2011). Additionally, the 
enzyme functions to reduce the mitochondrial permeability transition by inhibiting the 
activity of mitochondrial matrix isomerase cyclophilin D. Consequently cyclophilin D is 
involved in calcium mitochondrial efflux thus giving SIRT3 an indirect role in calcium 
homeostasis regulation. 
 
Figure 2.6: Summary of SIRT3 activity during stress conditions (prepared by author) 
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2.5.1.3 LON Protease 
Lon protease (LONP1) is a serine protease involved in the degradation of oxidatively 
damaged proteins. LONP1 contains a highly conserved ATPase domain with an AAA+ 
module and a proteolytic domain with a N-terminal domain (Ngo and Davies, 2007). 
The AAA+ module partakes in target selection with nucleotide binding and ATP 
hydrolysis due to a Walker motif (Neuwald et al., 1999). The confirmation of the LON 
complex is organ specific with 4-8 LON polypeptides binding together to form a homo-
oligometric complex.  
The site of action occurs at the N-terminus where the hydrophobic amino acid of 
protein substrates bind. Upon binding, ATP hydrolysis occurs allowing the protein to 
be passed through the Lon complex and proteolytic chamber. This is followed by 
protein cleavage (Figure 2.7) (Ondrovičová et al., 2005). 
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Figure 2.7: LONP1 proteolysis mechanism for damaged proteins (prepared by author) 
LONP1 has a high affinity for oxidatively damaged proteins, misfolded proteins and 
protein substrates exposed to stress conditions which all signal upregulation in LONP1 
expression (Ngo and Davies, 2007). A study carried out suggests that LONP1 has the 
ability to bind to mitochondrial DNA. Such binding is inhibited when LONP1 is 
sequestered by ATP. Hydrolysis of ATP during stress conditions allows for LONP1 
now bound to adenosine diphosphate (ADP) to rebind nucleic acids after regulation 
during stress. The function of the process remains elusive however, it has been 
suggested that this keeps LONP1 away from the mitochondrial matrix  to prevent 
26 
 
degradation of functional proteins while keeping the complex in close proximity in case 
of stress induction (Liu et al., 2004). 
LONP1 is post translationally regulated by SIRT3. SIRT3 deacetylates LONP1 causing 
decreases in protein expression. Silencing of SIRT3 causes increases in LONP1 
protein levels however, it has no effect on LONP1 mRNA thus allowing for LONP1 
activation or suppression in spite of SIRT3 presence (Bota et al., 2005, Gibellini et al., 
2014). 
2.5.1.4 Heat shock proteins 
During stress conditions genes and proteins involved in survival, detoxification, 
inflammation and death are activated or supressed accordingly. A special group of 
stress genes allow for the transcription of proteins namely heat shock proteins (HSPs). 
HSPs are molecular chaperones involved in correcting the folding of misfolded 
proteins that have occurred due to stress related incidences. Furthermore, HSPs 
prevent the aggregation of misfolded proteins.  Due to their distinct activity they are 
used as bio-markers for cellular stress and hazards. HSPs are classified based on 
their molecular weight, amino acid sequences and function. The proteins are 
separated into five main families including HSP- 100, -90, -70, -60 and -40 (Table 2.1) 
(Gupta et al., 2010). 
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Table 2.1: Summary of location and function of various HSPs (prepared by author) 
HSPs family Cellular Location Function 
HSP40 Cytoplasm and nucleus Regulates protein folding 
HSP60 Mitochondria Protein assembly, 
refolding of misfolded 
proteins and protein 
stability 
HSP70 Cytoplasm, ribosome 
and nucleus 
Assembly and transport 
of new proteins and 
removal of denatured 
proteins 
HSP90 Cytoplasm and nucleus Binds proteins and 
receptors in specific 
manner 
HSP100 Cytoplasm and nucleus Prevents aggregation 
and assist in refolding 
 
Heat shock protein 60 (HSP60) is mainly involved in polypeptide folding and 
translocation of proteins. Proteins of this family have been identified in the 
mitochondria of both bacteria and eukaryotes (Cappello et al., 2008). 
HSP60 is predominantly located in the human mitochondrial matrix where it aids in the 
folding of small monomeric soluble proteins and the refolding or misfolded proteins 
(Pellegrino et al., 2013). Furthermore, the chaperone transports certain proteins to the 
mitochondria when needed. Studies have shown a direct correlation in the 
upregulation of HSP60 expression in response to mitochondrial dysfunction, thus 
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making it a suitable marker for mitochondrial stress (Pellegrino et al., 2013). 
Additionally, HSP60 is known to play a role in ensuring protein stability through its 
ability to ensure correct folding of protein structures (Richter-Landberg and Goldbaum, 
2003).  
2.6 Mitophagy 
In the mitochondria, respiration results in the production of ROS. Alterations in 
mitochondrial respiration chain may cause exacerbated production of mitochondrial 
derived ROS, thus inducing cytotoxicity. Endogenous production of ROS causes the 
mitochondria to be susceptible to oxidative damage. This may induce ATP depletion 
from uncoupled OXPHOS and releases of cytochrome promoting caspase activation 
and apoptosis (Kim et al., 2007). Furthermore, mitochondria DNA lack histones, thus 
increasing their vulnerability to damage as opposed to nuclear DNA. Additionally, 
disease and exposure to toxins may exacerbate ROS production inducing stress and 
causing occurrence of dysfunctional mitochondria.  
Dysfunctional and damaged mitochondria trigger the activation of several proteins to 
ensure that compromised mitochondria are removed from the cell. This is carried out 
by autophagic sequestration followed by lysosomal hydrolytic degraded in a collective 
process named mitophagy (Figure 2.8). Mitophagy is promoted during states of 
mitochondrial stress and mitochondrial toxicity (Kim et al., 2007, Youle and Narendra, 
2011).  
Mitophagy was first observed in mammalian cells with increased mitochondrial 
sequestration by lysosomes following treatment with glucagon. Before mitophagy 
occurs in mammal cells, mitochondrial fission occurs to split elongated mitochondria 
in smaller fragments for easy encapsulation and as a quality control technique to 
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identify damaged mitochondria to be removed by mitophagy (Twig et al., 2008, 
Westermann, 2010). This may occur in diseased states or to control the required 
number of mitochondria needed in normal metabolic processes (Tal et al., 2007). 
 
Figure 2.8: Simplified diagram of the mitophagic process (Youle and Narendra, 2011) 
Once mitochondria are damaged or begin to lose membrane potential the kinase 
PTEN induced kinase 1 (PINK1) begins to accumulate around the mitochondria. This 
initiates the recruitment of the E3 ubiquitin ligase parkin from the cytosol to the injured 
mitochondria. The ligase causes engulfment of the mitochondria via isolation 
membranes that are later fused with lysosomes (Youle and Narendra, 2011). PINK1 
is expressed in all healthy mitochondria and constantly degraded by proteolysis whilst 
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maintaining a low level of the protein. When mitochondria are damaged this proteolysis 
is inhibited to allow for accumulation of PINK1 and progression of mitophagy. 
Following ubiquitylation via parkin, p62 gathers in the mitochondria. This protein has 
the ability to aggregate ubiquitylated structures via polymerisation with other p62 
molecules whilst recruiting these structures to phagosomes via binding to the protein 
LC3. In the same way p62 binds to parkin mitochondrial substrates and allows 
clumping of ubiquitylated mitochondria (Geisler et al., 2010, Narendra et al., 2010a, 
Narendra et al., 2010b). 
2.6.1 Regulation of mitophagy 
2.6.1.1 Nuclear factor (erythroid-derived 2)-like 2 
Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is a transcription factor that initiates 
first line defences to maintain homeostasis when deviations occur in cells.  These 
include irregularities such as oxidative stress, uncontrolled inflammation and 
xenobiotic exposure (Robledinos-Antón et al., 2019). Several toxicity studies have 
highlighted Nrf2 as a key marker during stress conditions and the expression of the 
transcription factor has been a target for manipulation by several toxins (Osburn and 
Kensler, 2008, Pillay et al., 2015, Loboda et al., 2017). 
Nrf2 remains in the cytoplasm when bound to Kelch like-ECH-associated protein 
(KEAP1), which marks it for ubiquitination and thereafter, proteasomal degradation. 
During stress conditions, Nrf2 is removed from KEAP1 via the disruption of cysteine 
residues in KEAP1. The KEAP1 association is disrupted and Nrf2 is no longer 
degraded but instead translocates to the nucleus. Once in the nucleus, Nrf2 is able to 
transcribe for various stress relieving genes, thus aiding in the amelioration of stress. 
The most common phenomenon that induces Nrf2 expression is the increased 
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production of ROS. Various studies have illustrated the role of Nrf2 in the reduction of 
oxidative stress via the transcription of antioxidant genes (Scannevin et al., 2012, 
Robledinos-Antón et al., 2019). 
Aside from its common antioxidant transcription function, Nrf2 has been shown to 
transcriptionally activate the upregulation of PINK1 and p62 during oxidative stress 
conditions (Jain et al., 2010, Murata et al., 2015). Therefore, Nrf2 has been described 
as a promoter of mitophagy. Nrf2 transcriptionally regulates PINK1 gene expression 
via activation of the antioxidant response element (ARE) sequence in the PINK1 
promoter region. The Nrf2-PINK1 axis has been shown to promote cell survival 
(Murata et al., 2015). In similar studies it was found that p62 has an ARE in its promoter 
region that allows for activation by Nrf2 during oxidative stress. This allows for increase 
in p62 protein expression and progression of mitophagy (Jain et al., 2010). 
2.6.2 Micro-RNAs 
MiRNA are small non-coding ribonucleotide acids (RNA) comprising of ~ 22 
nucleotides. Research has described the function of these molecules as gene 
expression modulators via protein translation inhibition (Figure 2.9). This has led to 
theories suggesting the miRNA can be used as biomarkers in disease as well as 
targets in therapeutic interventions. 
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Figure 2.9: Function of miRNA (prepared by author) 
MicroRNAs regulate protein expression via binding to the 3’-UTR of mRNA. The 
interaction between the mRNA and miRNA inhibits protein translation. The function of 
miRNA allows for regulation of various biological processes including cell proliferation, 
cell death and metabolism (Maltby et al., 2016, Hammond et al., 2001). 
2.6.2.2 MicroRNA-27b 
Previously miR-27b was known to  negatively regulate adipocyte differentiation via 
repression of peroxisome proliferator-activated receptor gamma (PPARγ) (Lin et al., 
2009). However, more recent studies show a new role of the miRNA in the negative 
regulation of mitophagy. MiR-27b repressed the expression of PINK1 via binding to 
the 3’-UTR of its mRNA thus preventing translation.  This repression prevents the 
progression of mitophagy and allows for accumulation of damaged mitochondria. The 
inhibition in PINK1 was coupled with decreases in parkin translocation and 
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ubiquitylation. Furthermore, miR-27b prevents lysosomal degradation of damaged 
mitochondria (Kim et al., 2016). 
2.7 Kidney structure and function 
The kidney is an excretory organ consisting of two bean shaped entities. They are 
located in the posterior section of the abdomen adjacent to both sides of the vertebral 
column (Radi, 2019). Primarily the kidney functions to regulate blood composition in 
humans. They control the concentration of water, buffers, molecules and electrolytes 
in the blood. Additionally, the kidney has the ability to remove organic molecules, 
metabolic waste, toxins and unnecessary metabolic by-products from the blood 
(Habuka et al., 2014). 
2.7.1 Basic kidney structure  
Each kidney comprises of a cortex with renal corpuscles, a medulla with medulla 
pyramids, renal papilla and renal pelvis. The medulla can be separated into an inner 
and outer region. The outer section of the medulla houses parts of the proximal tubule, 
distal tubes and collecting ducts. The proximal tubule is further divided into 3 
segments; S1, S2 and S3, all having different nutritional and energy requirements. S1 
segments have a high mitochondrial concentration with increased oxidative rates. S2 
have fewer mitochondria with more lysosomes. S3 segments houses cytochrome 
P450 enzymes which are essential for the metabolism of drugs and toxins (Radi, 
2019). 
The inner medulla may be identified by ascending thick limbs, descending thin limbs 
and collecting ducts. The cortex and the medulla have urinary producing entities 
namely nephrons. Nephrons are broken down into glomeruli, renal tubules, interstitium 
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and juxtaglomerular apparatus. The functional units of the kidney include the 
nephrons, renal corpuscle, proximal tubule, loop of Henle and distal tube (Radi, 2019). 
2.7.2 Kidney function 
Primarily the kidney has 6 main functions namely regulation of water and electrolyte 
in the body, endocrine functions (release of hormones), controls volumes of 
extracellular fluids, maintaining pH and pressure in blood, excretion of metabolic waste 
and metabolic function and biotransformation (Radi, 2019). 
2.7.3 Use of Hek293 cell line 
The Hek293 cell line has been used in numerous toxicology studies including those 
involving mycotoxins (Pillay et al., 2015, Zhang et al., 2015). The biochemical systems 
of the cell allow for efficient post-translational folding and processing required for 
protein and nucleic acid synthesis.  Furthermore, the cell line is favoured due to quick 
reproduction and maintenance. This allows for reputable analysis to profile the action 
of xenobiotics and their cellular targets (Thomas and Smart, 2005). 
Hek293 cells have an abundance of mitochondria and several studies have used the 
model to test mitochondrial function and dynamics (Mao et al., 2011, Seeland et al., 
2015). Furthermore, Hek293 cells have been used in studies determining the effects 
of mycotoxins on mitochondrial function. This makes the model suitable to test the 
effects of FB2 on the mitochondria of kidney cells (Liu et al., 2007, Pillay et al., 2015).  
2.7.4 Nephrotoxicity 
Blood flows at high volumes to the kidney whilst high oxygen consumption occurs at 
the site. This enhances organ’s susceptibility to exposure and injury caused by 
xenobiotics and chemicals through circulation (Gwaltney-Brant, 2018). 
35 
 
One of the primary routes of excretion of toxins is the kidney which consists of a vast 
array of biotransformation enzymes. This increases vulnerabilities to injury as the 
toxins present in the glomerular filtrate are concentrated, while the cortex receives 
80% of blood and as such exposure to higher concentrations of toxins occurs and 
toxins concentrate in the proximal tubule following reabsorption and secretion 
(Gwaltney-Brant, 2018).  
The resulting exposure and failure in detoxification may result in acute kidney toxicity 
(AKI) or chronic kidney disease (CKD). Acute renal failure is a rapid decrease in kidney 
function, which allows for accumulation of waste products. Chronic renal failure is the 
gradual decrease in kidney function and occurs during long term exposure to toxins. 
Compromised kidney function induces disturbances in homeostasis and limits 
excretory capacity (Gwaltney-Brant, 2018) 
2.7.5 Kidney and mitochondrial toxicity 
The kidney functions at a high rate requiring vast amounts of energy for efficiency. The 
primary form of energy production occurs via aerobic metabolism for ATP production 
via OXPHOS. Within the mitochondria of kidney cells, oxygen is reduced during the 
ETC under normal conditions. Furthermore, the ETC has various sites for ROS 
production. Dysfunction occurring in the ETC results in the inefficient control of ROS 
production and ultimately oxidative stress. Consequent decreases in mitochondrial 
membrane potential is noted and decreases in ATP production (Small et al., 2012). In 
several case of CKD and AKI impaired mitochondrial function was noted. Furthermore, 
several xenobiotics target mitochondria of the kidney inducing stress and bringing 
about injury (Granata et al., 2009). 
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Chapter 3: Materials and Methods 
Hek293 cells were used as a model to study the toxic effects of FB2 with specificity to 
mitochondrial toxicity (Figure. 3). The effect of FB at varying concentrations on cell 
viability over a period of 24 hr was established. The IC50 which is the concentration at 
which 50% growth inhibition had occurred was selected for treatment in subsequent 
assay. Furthermore, 100 µM (128.45% viability) and 500 µM (67.05% viability) were 
used in subsequent assay to achieve a broad spectrum toxic profile. The 
concentrations were selected within close proximity to levels of FB2 that humans are 
normally exposed to via consumption of contaminated food. These three 
concentrations were used in all experiments carried out to achieve the objectives of 
the study. 
 
 
 
Figure 3: Experimental approach used to determine the mitochondrial toxicity of FB2 
on Hek293 cells (Prepared by author). 
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3.1 Materials 
Hek293 cells were obtained from Highveld Biologicals (Johannesburg, South Africa). 
Cell culture media and supplements were sourced from Lonza (Basel, Switzerland). 
Luminometry kits were purchased from Promega (Madison, WI). Western blot 
reagents were purchased from Bio-Rad (Hercules, CA). All other reagents were 
purchased from Merck (Darmstadt, Germany) unless otherwise stated. 
3.2 Methods 
3.2.1 Cell culture and exposure protocol 
Hek293 cells were cultured in 25cm3 flasks using Dulbecco’s minimum essential 
medium (DMEM) supplemented with 2.5% HEPES, 10% foetal bovine serum, 1% pen-
strepfungizone, 1% L-glutamine and maintained in a humidified incubator (5% CO2) at 
37 °C.  
FB2 was purchased from Sigma and a stock solution of 20 mM was made up using 
0.1M phosphate buffered saline (PBS). This was diluted using DMEM to produce serial 
concentrations for the MTT assay (0-500 µM) and thereafter for further experiments.  
3.2.2 MTT assay 
3.2.2.1 Introduction 
The MTT assay is a colorimetric test used to measure cell viability. It is most commonly 
used to determine cytotoxicity of compounds of varying concentrations. The basic 
principle of the assay is based on mitochondrial activity where it is postulated that 
viable cells have constant mitochondrial activity. Therefore, an increase or decrease 
in cell viability is directly proportional to mitochondrial activity. During the assay 
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procedure, mitochondrial dehydrogenases convert the MTT salt into formazan yielding 
a colour change from yellow to purple (Figure 3.1).  
 
Figure 3.1: Conversion of MTT salt to formazan via mitochondrial reductase in viable 
cells (prepared by author). 
The concentration of solubilised formazan is measured using a spectrophotometer at 
570 and 690 nm. In cytotoxicity testing, decreased viability indicates growth inhibition 
and the toxin sensitivity is expressed at a concentration that induces 50% growth 
inhibition (IC50) (Van Meerloo et al., 2011). 
3.2.2.2 Protocol 
The cytotoxicity of FB2 in Hek293 cells was determined using the MTT assay. Briefly, 
20,000 cells/well (triplicate) were seeded and allowed to adhere overnight in a 96-well 
microtitre plate (37 °C; 5% CO2). Thereafter, cells were treated for 24 hr with varying 
concentrations of FB2 (0-500 µM). Control wells contained media only. Following the 
incubation (24hr), treatments were removed, cells were washed using 0.1M PBS and 
incubated with MTT salt (20 µl; 5mg/ml in 0.1M PBS) and complete culture medium 
(CCM) (100 µl) for 4hr. The MTT salt solution was then removed and 100 µl of dimethyl 
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sulphoxide (DMSO) was aliquoted per well, and incubated for 1 hr. Optical density was 
read using a spectrophotometer (BioTek uQuant) at a wavelength of 570 nm and a 
reference wavelength of 690 nm. Results were expressed as log concentration versus 
percentage cell viability.  
Following the MTT assay, an IC50 (317.4µM of FB2) was determined and was used in 
all subsequent experiments. In addition, 100 µM (low dose) and 500 µM (high dose) 
of FB2 were used in experiments. The 100 µM (128.45% viability) concentration of FB2 
demonstrated cell proliferation, whereas the 500 µM (67.05% viability) showed the 
highest inhibition of cell viability. 
3.2.3 ATP assay 
3.2.3.1 Introduction 
ATP is an essential energy source for all cells. The mitochondria produce the highest 
percentage of ATP via the ETC coupled to OXPHOS and substrate level 
phosphorylation with cytoplasmic glycolysis accounting for a smaller percentage. To 
quantify ATP concentration, the CellTiter-Glo® (Promega) kit was used. The assay 
uses luminometry to measure bioluminescence. Bioluminescence occurs when a 
chemiluminescent reaction (Figure 3.2) takes place (Deshpande, 2001). 
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Figure 3.2: Principle of the CellTiter-Glo® assay used to measure concentration of 
intracellular ATP (Deshpande, 2001). 
The reaction results in the conversion of chemical energy to light. The first stage of the 
reaction is the creation of large amounts of energy using a substrate (D-luciferin), ATP, 
oxygen and a magnesium co-factor. This reaction is enzymatically regulated by 
luciferase. Luciferin is converted to oxyluciferin. The chemical energy produced in the 
first stage excites and increases the energy of the luminescent molecule. This results 
in decay and photon emission, which then releases light. The light produced is directly 
proportional to the ATP produced by the cell and light intensity measured using a 
luminometer (Deshpande, 2001). 
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3.2.3.2 Protocol 
ATP concentration was measured following the CellTiter-Glo® Luminescent Cell 
Viability Assay (Promega, catalogue no. #G7570). Cells were treated in 6 well plates 
for 24 hr (37 °C; 5% CO2). Following treatment, cells were counted and adjusted using 
the Trypan blue exclusion method and 20,000 cells in 0.1M PBS were seeded per well 
in triplicates (25 µl/well) using an opaque 96 well microtitre plate. As per 
manufacturer’s instructions, the CellTiter-Glo® Reagent was reconstituted and 25 µl 
of reagent was added to each well. Plates were incubated in the dark for 20 mins at 
room temperature (RT), and luminescence was measured using a Modulus™ 
Microplate Reader. Results were expressed as concentration versus relative light units 
(RLU). 
3.2.4 H2DCF-DA assay 
3.2.4.1 Introduction  
Reactive oxygen species (ROS) is endogenously produced by cells however, this 
production may be stimulated by external factors resulting in an over production of 
ROS. The imbalance between ROS and antioxidants results in oxidative stress, thus 
the need to measure ROS level in cells. The most suitable methods for ROS 
measurement in live cells are fluorescent techniques where the fluorescence 
indicators are susceptible to fluctuations in ROS concentration. The 2, 7-
dichlorohydrofluorescein diacetate (H2DCF-DA) assay uses a dye that emits low 
fluorescence in a reduced state but is highly fluorescent in an oxidised state - 
dichlorofluorescein (DCF). H2DCF-DA diffuses into cell due to its cell permeable 
nature and is cleaved by endogenous esterases (Figure 3.3). This process yields the 
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H2DCF- anion which is non-fluorescent. Exposure to ROS results in the anion being 
reduced to DCF, which is high fluorescent.  
 
Figure 3.3: Principle of DCF assay for ROS detection (prepared by author) 
The fluorescent intensity is directly proportional to the ROS produced by the cell and 
measured using a fluorometric plate reader (Wang and Roper, 2014). 
3.2.4.2 Protocol 
ROS concentration was quantified using the DCF assay. Cells were treated in 6 well 
plates at a confluency of 80% for 24 hr (37 °C; 5% CO2). Cells were counted and 
adjusted using the Trypan blue exclusion method and 50,000 cells were seeded in 
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four separate microcentrifuge tubes. A stock solution of 80 mM H2DCF-DA was diluted 
to produce a concentration of 5 µM in PBS; 100 µl of the working solution was added 
to each microcentrifuge tube (37 °C; 30 mins). Cells were washed with PBS and 
subsequently centrifuged (400 xg; 10 mins). PBS was removed and the process was 
repeated. Cells were. Fluorescence resuspended in 200 µl of PBS and transferred to 
opaque 96-well microtitre plates was measured using a Modulus™ Microplate Reader 
with a blue filter (excitation wavelength 503nm, emission wavelength 509nm) and 
results expressed as relative fluorescent units (RFU). 
3.2.5 JC-1 Mitoscreen 
3.2.5.1 Introduction 
The mitochondria are the locations for several major events however, the most 
significant is the loss of mitochondrial membrane potential (Δψm) (Green and Reed, 
1998). The mitochondria generate an electric gradient across their membrane to 
produce ATP. The direction of the membrane potential allows for transport of cations 
in the mitochondria and outward transport of anions.  This gradient drives ATP 
synthesis. However, certain toxins have the ability to decrease Δψm leading to 
dysfunction in mitochondrial process (Sivandzade et al., 2019). 
The JC-1 mitoscreen uses the JC-1 dye to detect Δψm in cells. The dye is a cation 
that naturally emits green fluorescence and possesses the ability to enter and 
accumulate in the mitochondria. Once inside the mitochondria, it begins to form J-
aggregates. These complexes exhibit excitation and emission in the red spectrum, as 
opposed to the JC-1 dye, which is in the green spectrum. Therefore, in healthy 
mitochondria they enter and form aggregates emitting red fluorescence. Conversely, 
in dysfunctional mitochondria, they enter less frequently due to the loss in Δψm and 
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the interior of the mitochondria being less negative. This causes the dye to be at 
insufficient concentrations to form aggregates and it remains in its green fluorescent 
state (Figure 3.4) (Sivandzade et al., 2019).  
 
Figure 3.4: Different results produced in healthy and unhealthy mitochondria following 
the JC-1 mitoscreen (Sivandzade et al., 2019). 
The ratio of red-green fluorescence in the mitochondria is proportional to the state of 
polarisation, the higher the Δψm, the higher the red emission and the lower the Δψm, 
the higher the green emission. Therefore, mitochondrial depolarisation is confirmed by 
reduced red-green fluorescent ratio (Sivandzade et al., 2019). 
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3.2.5.2 Protocol 
The mitochondrial membrane potential (Δψm) was measured using the JC-1 stain 
(Zheng et al., 2013). Control and treated cells (50,000 cells per treatment) were 
incubated in 200 μl of 5 μg/ml JC-1 stain (BD Biosciences, San Jose, NJ, USA) (20 
min, 37 °C). The stain was removed via centrifugation (400 x g, 10 min, 24 °C) and 
the cells were washed twice with JC-1 staining buffer. Cells were re-suspended in 400 
μl of JC-1 staining buffer and seeded in an opaque 96-well plate in triplicate (100 
μl/well). A blank, which consisted of only JC-1 stain buffer was plated in triplicate in 
wells (100 μl/well). Fluorescence was quantified on a Modulus™ microplate reader 
(Turner Biosystems, Sunnyvale, CA). JC-1 monomers are measured with a blue filter 
(excitation wavelength 488 nm, emission wavelength 529 nm) and JC-1 aggregates 
are measured with a green filter (excitation wavelength 524 nm, emission wavelength 
594 nm). The Δψm of the Hek293 cells are expressed as the fluorescence intensity 
ratio of JC-1 aggregates and JC-1 monomers. 
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3.2.6 Western blots 
3.2.6.1 Introduction 
Western blots are used to detect proteins of interest using a multi-step process (Figure 
3.5). Proteins are initially separated by size using electric fields and thereafter are 
transferred to a membrane for detection. Thereafter antibodies may be used to probe 
for the protein of interest. The technique allows for the determination of protein levels, 
which are expressed in relation to band density obtained (Manns, 2011, Bass et al., 
2017). 
 
Figure 3.5: Summary of western blot procedure (Bass et al., 2017) 
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3.2.6.2 Protein isolation and sample preparation 
Cells are lysed and proteins are solubilised using different detergents and buffers. To 
prevent protein degradation proteases and phosphatase inhibitors are used during this 
process. Following protein extraction, the bicinchoninic acid (BCA) assay is used to 
quantify the protein concentration. This is carried out to ensure that enough protein is 
available and allows for protein concentration to be adjusted to ensure even 
concentrations between samples during separation. The BCA assay relies on the 
conversion of cupric (Cu2+) to cuprous ion (Cu+). The produced Cu+ reacts with the 
BCA reagent and this allows for detection. The reaction yields an intense purple colour 
that is detected at a wavelength of 562 nm using a spectrophotometer. The intensity 
of colour produced is directly proportional to protein concentration. Considering that 
the Cu+ formed is a function of protein concentration, unknown protein concentrations 
may be determined by comparison with known standard proteins (Walker, 2009). 
Once proteins have been quantified and standardised they are diluted with Laemmli 
buffer. The buffer comprised of the following components with specific functions 
(Gavini and Parameshwaran, 2019): 
 Glycerol- increases the viscosity of the sample allowing it to sink into wells 
 Sodium dodecyl sulphate (SDS) - causes the protein sample to have a 
homogenous negative charge and ensure linearization of protein samples. 
 Tris- maintains the pH of the sample 
 Β-mercaptoethanol- breaks down disulphide bridges and bond in proteins 
promoting linearity. 
 Bromophenol blue- acts as a tracking dye for proteins during electrophoresis  
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3.2.6.3 SDS-PAGE 
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) is used to 
separate proteins after which the relative molecular mass, relative concentration and 
purity of proteins may be determined.  SDS-PAGE allows for the movement of charged 
molecules through a gel matrix following application of an electric current (Manns, 
2011). 
SDS is a negatively charged detergent that can denature proteins and give them an 
overall negative charge. The proteins solubilised by SDS possess a larger negative 
charge in proportion to mass and this influences the rate at which they move towards 
the anode under the influence of an electric field (Manns, 2011). 
Polyacrylamide creates a gel matrix, which acts as a filter allowing for small molecules 
to migrate at a faster rate than larger molecules. A greater percentage of acrylamide 
results in smaller pores, while a lower percentage of acrylamide results in larger pores. 
The gel has two sections namely the resolving and stacking gel. The stacking gel has 
a lower percentage of acrylamide and forms part of the starting point of migration 
allowing the proteins to form thin defined bands. The resolving gel has a higher 
percentage of acrylamide and is more important for protein separation by size (Manns, 
2011). 
The rate of migration is influenced by gel pore size, protein size, charge and shape. 
Proteins migrate after a current is applied and differentially migrate with larger proteins 
staying closer to the origin and smaller proteins migrating further down the gel. 
Molecular weight markers are used to aid in determination of the sizes of unknown 
proteins (Manns, 2011). 
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3.2.6.4 Transfer of proteins 
Following protein separation, the proteins are transferred to a nitrocellulose 
membrane. This is performed using an electric field that is perpendicular to the gel 
allowing proteins to migrate from the gel onto the membrane. This is created by placing 
the membrane between the gel and a positive electrode creating a sandwich that is 
protected by fibre pads at each end. The process is known as electrophoretic transfer 
(Bass et al., 2017). 
3.2.6.5 Immuno-blotting 
Prior to immune blotting, membranes with protein are incubated in a diluted protein 
such as bovine serum albumin (BSA) or non-fat dry milk in a blocking step. This 
prevents non-specific binding of antibody to the membrane and reduces background 
to yield more accurate results (Gavini and Parameshwaran, 2019). 
Following this step, a non-labelled primary antibody is used to bind to the protein of 
interest followed by a labelled secondary antibody to bind to the primary antibody. The 
labelled secondary antibody is conjugated to an enzyme commonly horseradish 
peroxidase (HRP) or alkaline phosphatase and aids in signal amplification.  The 
enzyme is able to oxidise the chemiluminescent detection reagent (luminol) to produce 
light. The light intensity is directly proportional to expression of the protein of interest 
(Gavini and Parameshwaran, 2019). 
3.2.6.6 Detection  
The resultant signals produced are detected using a camera based imager, generally 
the image shows one or more protein bands and comparison of the band to the 
molecular weight marker can be used to determine the size of the proteins. Quantity 
of the protein is determined in relation to band intensity. A housekeeping protein is 
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used to normalise protein expression in order to determine accurate protein levels. 
Housekeeping proteins are internal reference proteins that are expressed 
constitutively and are used as a corrective measure to minimise errors occurring 
during loading and varying protein concentrations (Gavini and Parameshwaran, 2019). 
3.2.6.7 Protocol 
Protein expression of regulatory mitochondrial proteins was assessed by western 
blots. Proteins were isolated in a single experiment prior to western blots. Following 
treatment for 24 hr, cells were incubated with 150 µl of Cytobuster™ Reagent 
(Novagen, San Diego, CA, USA, catalogue no. 71009) on ice for 30 mins. Cells were 
lysed mechanically via scraping. Lysed cells were transferred to 1.5 ml microcentrifuge 
tubes and centrifuged (400 x g, 10 mins, 4 °C). The supernatant containing crude 
protein isolates were aspirated and quantified. The BCA assay was used for 
quantification;  protein samples were standardised to a concentration of 1.5 mg/ml. 
Protein samples were boiled in Laemmli Buffer containing distilled water, glycerol, 10% 
SDS, β-mercaptoethanol, 0.5M Tris-HCl (pH 6.8), 1% bromophenol blue and glycerol 
(5 mins; 100 °C). 
A Bio-Rad compact supply was used to electrophorese 25 µl samples (1hr at 150V) in 
sodium dodecyl sulphate (SDS) polyacrylamide gels (4% stacking, 10% resolving). A 
Bio-Rad Trans-Blot® Turbo Transfer system was used to transfer proteins from the 
gel onto nitrocellulose membranes using a pre-programmed protocol for mixed 
molecular weight. All membranes were blocked using 5 ml of 5% Bovine Serum 
Albumin (BSA) (1 g BSA in 100 ml Tris-buffer saline [TTBS-0.5% Tween20, dH2O, 
KCl, NaCl, Tris, pH 7.5]).  
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Membranes were then immunoprobed with the respective primary antibody (1:1000 
dilution in 5% BSA) against) phosphorylated (Ser40) Nrf2 (ab76026, Abcam), SIRT3 
(ab86671, Abcam), LONP1 (HPA002192, Sigma- Aldrich), PINK1 (a23707, Abcam), 
p62 (a56416, Abcam) and HSP60 (SAB4501464, Sigma-Aldrich) for 1hr at RT on a 
shaker and thereafter, overnight at 4 °C. Following incubation, membranes were 
washed (x5) for 10 mins using 5 ml of TTBS. Membranes were then incubated in HRP 
conjugated secondary antibodies (Cell signalling Technology- anti-mouse, anti-rabbit) 
(1:5000 in 5% BSA) for 1hr at RT on a shaker. Membranes were then washed (5 x 10 
mins) using 5ml of TTBS and rinsed with distilled water. Clarity Western ECL Substrate 
detection reagent (400µL) (Bio-Rad) was added to membranes to detect bands and 
images were captured on a Bio-Rad ChemiDoc™ XRS+ System. Results were 
analysed using Image Lab™ Software v6.0 (Bio-Rad). 
Membranes were quenched using 5% hydrogen peroxide for 30 mins at 37 °C, blocked 
using 5% BSA and incubated in HRP-conjugated antibody for β-actin (A3854, Sigma-
Aldrich) as a house-keeping protein. Results were presented as relative band density 
(RBD) of protein of interest divided by RBD of respective β-actin. 
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3.2.7 Quantitative PCR 
3.2.7.1 Introduction 
Conventional polymerase chain reaction (PCR) is use to amplify a specific DNA 
sequence from template strands. The method employs the use of primers which are 
single stranded DNA that flank the targeted gene. Primers are then extended via DNA 
polymerase (Taq polymerase) which allows for the addition of deoxynucleotide 
triphosphates (dNTP) to the 3’ end of primers. The three main steps in PCR include: 
(Figure 3.6) (Garibyan and Avashia, 2013). 
1. Denaturation (90 °C) - Heating of sample where double stranded DNA (dsDNA) 
is separated to produce single stranded DNA (ssDNA). These act as templates. 
2. Annealing (55 °C -60 °C) - Primers bind to the complementary bases from the 
3’ end of the template. 
3. Extension (72 °C) – Annealed primers have dNTPs added on via DNA 
polymerase to produce new dsDNA. 
The process results in the exponential amplification of DNA however, it does not allow 
for the quantification of the synthesised products. 
Quantitative PCR is used for the quantification of nucleic acids. The method allows for 
the reliable detection and measurement of products produced during each PCR cycle. 
Isolated RNA are reverse transcribed into complementary DNA (cDNA). This cDNA 
acts as a template for conventional PCR to continue. SYBR green intercalates 
between bases in the dsDNA synthesised. Due to the dye being fluorescent, the 
fluorescence intensity is measured to quantify amplified DNA. A housekeeping gene 
is used to normalise gene levels and concentrations of target DNA expressed in 
relation to the amount of housekeeping gene (Garibyan and Avashia, 2013). 
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Figure 3.6: Principle of qPCR (Garibyan and Avashia, 2013). 
3.2.7.2. Protocol 
RNA isolation 
Following treatment for 24 hr, cells were incubated with 500 µl each of Trizol and PBS 
(5mins; RT). Samples were scraped and transferred to 2 ml microcentrifuge tubes and 
stored (24 hr, -80 °C).  The samples were thawed at RT, followed by the addition of 
100 µl of chloroform and centrifugation (12000 g, 10 mins; 4 °C). The supernatant was 
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removed and 250 µl of isopropanol added followed by storage at -80°C overnight. 
Samples were then thawed at RT and centrifuged (12000 g, 20 mins; 4 °C).   The 
supernatant was discarded and the pellet preserved and washed using 500 µl of 
ethanol. Following washing samples were centrifuged (7400 g, 15 mins; 4 °C).  The 
ethanol was removed and the pellet left to air dry (20-30 min, 24 °C). Once dry, pellets 
were resuspended in 15 µl of Nuclease-Free water and samples were stored at -80 
°C. 
RNA quantification 
Quantification of the crude RNA product was carried out using the Nanodrop2000 
Spectrophotometer (Thermo-Fisher Scientific). RNA quality was determined using 
A260/A280 ratio. All RNA samples were standardised to 500 ng/µl. 
cDNA synthesis 
i. cDNA synthesis for mRNA 
The cDNA was synthesized from the crude RNA samples using the iScript™ cDNA 
Synthesis kit (Bio-Rad, catalogue no 107-8890).  A master mix was created using 
reagents from the kit and standardised RNA (Table 3.1). 
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Table 3.1: cDNA synthesis (iScript cDNA synthesis kit, Bio-Rad). 
Component 1 x Reaction (µl) 
5x iScript Reaction Mix 2 
iScript Reverse 
Transcriptase 
0.5 
Nuclease-Free Water 5.5 
RNA Template (500ng/μl) 2 
Total 10 
 
The 10 µl Master Mix was used to synthesis cDNA and incubated in a thermocycler 
(GeneAmp® PCR System 9700, Applied Biosciences, California, USA) [25 °C for 5 
min, 42 °C for 30 min, 85 °C for 5 min, 4°C hold]. Following synthesis, cDNA was 
stored at -20 °C until further use. 
ii. cDNA synthesis for miRNA 
The cDNA was synthesized from crude RNA samples using the miScript® II RT Kit 
(Qiagen, Hilden, Germany; catalogue number 218160).  A master mix was created 
using reagents from the kit and standardised RNA (Table 3.2). 
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Table 3.2: cDNA synthesis (miScript® II RT kit, Qiagen). 
Component 1 x Reaction (µl) 
5x miScript HiFlex Buffer 4 
10x miScript nucleics mix 2 
Nuclease-Free Water 10 
miScript RT mix 2 
RNA template (500ng/μl) 2 
Total 20 
 
The 20 µl Master Mix was used to synthesis cDNA and incubated in a thermocycler 
(GeneAmp® PCR System 9700, Applied Biosciences, California, USA) [37 °C for 60 
min, 95 °C for 5 min and 4 °C for 5 min]. Following synthesis, cDNA was stored at           
-20 °C until further use. 
Gene expression 
i. mRNA gene expression 
Gene expression of SIRT3 and PINK1 (Table 3.3) was assessed using the iQ™ 
SYBR® Green PCR kit and the CFX Touch™ Real Time PCR Detection System 
(Bio-Rad, Hercules, CA, USA). A master mix was created using the cDNA and 
reagents from the kit (Table 3.3). 
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Table 3.3: Reaction mix for qPCR (iQ™ SYBR® Green PCR kit) 
Component 1x Reaction (µl) 
SYBR® Green 5 
Forward primer 1 
Reverse primer 1 
Nuclease-Free Water 2 
cDNA template 1 
Total  10 
 
The thermocycler conditions for each gene were as follows: initial denaturation              
(8 mins, 95 °C), followed by 40 cycles of denaturation (15 sec, 95 °C), annealing (Table 
3.4), extension (30 sec; 72 °C) and  final extension (30sec; 72 °C). Data was 
normalized against housekeeping gene GAPDH. Results were analysed using the 
Livak and Schmittgen (2001) method and represented as fold change relative to the 
housekeeping gene (2−ΔΔCt) (Livak and Schmittgen, 2001).  
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Table 3.4: Primers sequences with respective annealing temperatures for genes 
assessed 
Gene  Sequence (5’-3’) Annealing 
temperature 
(°C) 
SIRT3 Sense  
Anti-sense  
GAGCGGCCTCTACAGCAAC 
GAGTAGTGAGTGACATTGGG 
60 
PINK1 Sense  
Anti-sense 
AAGCGAGGCTTTCCCCTAC 
GCACTACATTGACCACCGATTT 
56 
GAPDH Sense  
Anti-sense 
TCCACCACCCTGTTGCTGTA 
ACCACAGTCCATGCCATCAC 
- 
 
ii. MiRNA gene expression 
MiRNA expression for miR-27b was assessed using the MiRNA SYBR® Green PCR 
Kit and CFX Touch™ Real Time PCR Detection System (Bio-Rad, Hercules, CA, 
USA). A master mix was created using the cDNA and reagents from the kit (Table 
3.5). 
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Table 3.5: Reaction mix for qPCR (MiRNA SYBR® Green PCR Kit). 
Component 1x Reaction (µl) 
2x Quantitect 
SYBR® Green mix 
6 
10x miScript 
universal primer 
1.25 
10x miScript primer 
assay 
1.25 
RNase-Free Water 2.25 
cDNA template 1 
Total  12 
 
The thermocycler conditions were as follows: initial denaturation (15 mins, 95 °C), 
followed by 40 cycles of denaturation (15 sec, 94 °C), annealing (30 sec; 55 °C ) and 
extension (30 sec; 70 °C). Data was normalized against housekeeping gene, RNU6 
(218300, MS00033740). Results were analysed using the Livak and Schmittgen 
(2001) method and represented as fold change relative to the housekeeping gene 
(2−ΔΔCt) (Livak and Schmittgen, 2001).  
3.2.8 Statistical analysis 
All assays were carried out in duplicates with a minimum of three replicates for each 
treatment unless stated otherwise. Data was analysed using One-way analysis of 
variance (ANOVA) followed by a Bonferroni test for multiple group comparison 
(GraphPad Prism V5.0 Software). Data was considered significant with p<0.05.  
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Chapter 4: Results 
4.1 Cell Viability 
Cytotoxicity was determined using serially diluted concentrations of FB2 (0-500 µM) in 
Hek293 cells over 24 hr. Analysis of the curve indicated that 317.4 µM of FB2 was 
sufficient to induce 50% cell death in Hek293 cells (IC50) (Figure. 4.1). Furthermore, 
100 µM (128.45% viability) showed the highest increase in cell viability and 500 µM 
(67.05% viability) showed the second highest inhibition of cell viability. These 
concentrations were used for treatment in subsequent assays to achieve a broader 
toxic profile. 
 
 
Figure 4.1: FB2 is cytotoxic to Hek293 cells. A dose dependent decline in viability of 
the cell occurred after treatment with varying concentrations (0 -500 µM) of FB2. 
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4.2 FB2 induced mitochondrial stress 
We next tested the effects of FB2 on mitochondrial stress - western blot for HSP60 
protein and luminometry for ATP quantification (mitochondrial functionality) was 
carried out. FB2 induced an increase in HSP60 protein expression suggesting 
increased mitochondrial stress (Figure 4.2A). Results showed a significant decrease 
in ATP (p<0.001) in the IC50 treated Hek293 cells when compared to the control 
whereas the 500 µM of FB2 showed a significant increase (p<0.001) in ATP levels 
when compared to the control (Figure 4.2B). The 100 µM concentration displayed no 
significant difference in ATP (Figure 4.2B). 
 
 
Figure 4.2: FB2 induced mitochondrial stress. HSP60 protein expression increased in 
a dose-dependent manner (A). ATP concentrations exhibited a biphasic response 
following treatment with FB2 (B). *p<0.05; **p<0.001; ***p<0.0001 relative to control 
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4.3 FB2 increased ROS production and mitochondrial membrane 
depolarisation 
Compromised mitochondrial function may result in exacerbated ROS production that 
further induces mitotoxicity. ROS production increased significantly for higher 
concentrations of FB2 (p<0.0001) whilst the lower concentration showed a significant 
decrease in ATP concentration (p<0.0001) (Figure 4.3A). Mitochondrial functionality 
can be observed by quantifying mitochondrial membrane depolarisation. Significant 
increases in mitochondrial membrane depolarisation were noted at higher 
concentrations (p<0.001)  whilst the percentage of depolarised membranes were 
lower at the lowest treatment of FB2 (p<0.0001) (Figure 4.3B).  
 
Figure 4.3: FB2 increased ROS production and mitochondrial membrane 
depolarisation. ROS production was supressed at lower concentrations however, 
significant increases were noted at higher treatments (A). Mitochondrial membrane 
depolarisation also significantly increased at higher concentrations (B).   A- **p<0.001; 
***p<0.0001 relative to control ; B  **p<0.001; ***p<0.0001 % depolarisation relative to 
control. 
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4.4 FB2 induced mitochondrial stress responses 
To confirm the induction of mitochondrial stress, protein (western blots) and mRNA 
(qPCR) levels of SIRT3 were analysed. Additionally, protein expression of LONP1 
(activated by SIRT3) was measured. Biphasic changes in the protein expression of 
SIRT3 were observed (Figure 4.4A). Gene expression of SIRT3 was significantly 
downregulated at the IC50 (p<0.05) (Figure 4.4C). Protein expression of LONP1 was 
significantly upregulated at the lowest treatment (p<0.0001) (Figure 4.4B) correlating 
to increase in SIRT3 protein expression (Figure 4.4A) 
 
Figure 4.4: FB2 induced a biphasic mitochondrial stress responses. SIRT3 protein 
expression was up-regulated at 100µM and 500µM, but down-regulated at IC50 when 
compared to the control (A). SIRT3 gene expression is supressed at the IC50 (C). 
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LONP1 expression increases at lower concentrations but decreases at higher 
concentrations (B). *p<0.05; **p<0.001; ***p<0.0001 relative to control. 
4.5 FB2 promoted mitophagy via Nrf2 activation 
Following FB2 exposure, significant increases in phosphorylated Nrf2 (Ser40) were 
noted for all treatment concentrations (Figure 4.5). Phosphorylated Nrf2 (Ser40) is the 
activated form of Nrf2 that has dissociated from KEAP1 allowing it to transcribe for 
proteins. The lowest concentration exhibited the most significant increase in 
phosphorylated Nrf2 (Ser40) (p<0.0001). 
 
Figure 4.5: FB2 promoted mitophagy. Significant upregulations in phosphorylated Nrf2 
(Ser40) expression following FB2 treatment. **p<0.001; ***p<0.0001 relative to the 
control. 
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4.6 FB2 induced mitophagy 
We screened Hek293 cells treated with FB2 for mitophagy via analysis of mitophagic 
proteins and genes. Epigenetic regulation of the markers were assessed via 
evaluation of a miRNA (miR-27b). Protein expression of PINK1 and p62 was quantified 
to conclude if mitophagic markers were upregulated. Western blots revealed that an 
increase in PINK1 transcript levels (Figure 4.6C) resulted in an increase in protein 
expression (Figure 4.6B) with concomitant decreases at lower concentrations. FB2 
correspondingly increased expression of p62 (Figure 4.6D) (p<0.0001). Gene 
expression of miR-27b is supressed for exposure to all concentrations of FB2. 
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Figure 4.6: FB2 increased mitophagy markers in Hek293 cells. PINK1 protein (A) and 
gene expression (B) was significantly up-regulated at the higher concentrations of FB2. 
Significant up-regulation in p62 protein as compared to the control was noted at high 
treatment concentrations (C). MiR-27b expression exhibited downregulation in 
comparison to the control (D) *p<0.05; **p<0.001; ***p<0.0001 relative to control. 
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Chapter 5: Discussion 
The toxicity exhibited by FB1 through inhibition of sphingolipid metabolism is well 
established (Wang et al., 1991). FB2 being the structural analog of FB1 has shown to 
mimic toxicity leading to diseases such as ELEM (Thiel et al., 1991). However, minor 
differences in the structure, accounting for increased polarity in FB2 and possible 
greater toxic potential. Aside from the mechanism of sphingolipid metabolism 
disruption, FB1 has been shown to induce mitochondrial toxicity. The toxin possesses 
the ability to inhibit complex I of the mitochondrial respiratory chain resulting in a 
decrease in mitochondrial respiration, increase in mitochondrial membrane 
depolarisation and oxidative stress as well as disturbance in calcium signalling 
(Domijan and Abramov, 2011, Arumugam et al., 2019). The present study supports 
the hypothesis that FB2 has similar mechanisms of toxicity as FB1 in relation to 
interference of mitochondrial function. 
FB2 supressed mitochondrial stress responses, induced ROS production and 
increased mitophagy markers at high dose exposure. These results illustrate the toxic 
potential of FB2 in inducing cell death via induction of mitochondrial dysfunction. 
Exposure to low doses of the compound proved to upregulate mitochondrial stress 
responses, reducing mitochondrial stress and mitophagy accounting for the 
proliferative and probable oncogenic properties of the toxin (Ueno et al., 1997). The 
concentration dependent effects of FB2 suggest that exposure to both low and high 
concentrations of the compound may induce severe side-effects on the consumer. 
The MTT assay was used to select concentrations causing cell death and proliferation 
to achieve a broader toxic profile. The WHO has reported that numerous countries 
exceed the tolerable intake limit of 2 µg/kg FB2 per day with some countries being 
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exposed to more than 15 µg/kg body weight (Shephard et al., 2007). Based on this 
data, concentrations were selected within close proximity to these values to ensure 
accurate representation of data. 
A common marker for compromised mitochondrial activity is reduced ATP production 
and an increase in mitochondrial stress markers. Previous studies have shown a direct 
correlation in the upregulation of HSP60 protein expression in response to 
mitochondrial stress making it a suitable bio-marker for the phenomenon (Pellegrino 
et al., 2013). Alternatively in excessively high stress conditions, cells are able to 
increase the rate of cytoplasmic glycolysis resulting in greater ATP production. This 
increase in ATP is annotated to certain mitochondrial stress mediators such as LONP1 
and HSP60 being ATP-dependent proteins (Pellegrino et al., 2013). Figure 4.2 shows 
that both phenomena were observed. The IC50 significantly increased HSP60 protein 
expression and reduced ATP production. FB2 is structurally similar to FB1 having an 
amino group that has been suggested as an imperative moiety for FB1 toxicity 
(Gelderblom et al., 1993). Previous studies have implicated FB1 in the inhibition of 
complex I in the ETC. The mechanism was compared to that of rotenone in inhibition 
of complex I, thus supressing its function and inducing perturbations in the ETC. 
Rotenone is able to bind to sites on complex I via structures similar to that of quinone 
(recognised by complex I) (Heikkila et al., 1985, Domijan and Abramov, 2011). In 
similar ways, FB1 is able to bind to sites on complex I that recognise the functional 
groups (Domijan and Abramov, 2011). The structural similarities between FB2 and FB1 
may allow the toxin to bind to complex I and cause inhibition in mitochondrial 
respiration. The reduction observed in ATP production (Figure 4.2B)  may have 
resulted due to inhibition of complex I in the ETC suggesting a similar mechanism of 
toxicity of FB2 as FB1 in human neuroblastoma (50 µM, 24 hr)  (Domijan and Abramov, 
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2011). The highest concentration increased both HSP60 protein expression and ATP 
production as a survival mechanism (Figure 4.2). No significant changes occurring in 
ATP levels for the lowest concentration (Figure 4.2B) accounts for the proliferation 
observed (Figure 4.1) suggesting the presence of healthy mitochondria. This is further 
verified by minimal mitochondrial stress (Figure 4.2A). 
A common consequence of dysregulation of mitochondrial dynamics is  depolarisation 
of the mitochondrial membrane (Domijan and Abramov, 2011). An increase in ROS 
production contributes greatly to both depolarisation and stress of the mitochondria. 
The ETC has various sites for ROS production and complications in the process 
induce inefficient control of ROS production and ultimately oxidative stress. 
Consequently, the increase in ROS production causes decreases in mitochondrial 
membrane potential and mitochondrial production of ATP (Small et al., 2012). Toxins 
such as FB1 have the ability to inhibit complexes in the ETC thus exacerbating ROS 
production and reducing the membrane potential in mitochondria (Domijan and 
Abramov, 2011). The present study suggests that FB2 acts in a similar way with 
increased production in ROS and an increase in mitochondrial membrane 
depolarisation at high concentration exposure (Figure 4.3). This is attributed to 
inhibition of complex I by FB2 suggested due to the reduction in ATP observed (Figure 
4.2B) correlating with the investigation carried out using FB1 in human neuroblastoma 
(50 µM, 24 hr)  (Domijan and Abramov, 2011). Consequences of altered mitochondrial 
membrane potential include modification in proliferation and cell death as seen during 
viability testing (Figure 4.1) (Zorova et al., 2018). Alternatively, it was noted that FB2 
increased the percentage of polarised mitochondria at the lowest concentration 
(Figure 4.3B). This data correlates with minimal ROS production (Figure 4.3A) and 
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unaltered ATP production (Figure 4.2B) proposing that at low concentrations, the 
functional groups of FB2 do not bind to complex I of the ETC. 
Mitochondrial SIRT3, a deacetylase, is a key regulator of mitochondrial homeostasis 
and antioxidant response to ROS (Huang et al., 2010).  Previous studies have shown 
increases in SIRT3 expression following induction of mitochondrial stress and 
inhibition in expression has led to mitochondrial toxicity and cell death due to inefficient 
stress response. Therefore, fluctuations in SIRT3 expression can be considered a bio-
marker for mitochondrial stress (Weir et al., 2013). Although SIRT3 cannot directly 
reduce mitochondrial stress, it deacetylates antioxidants such as superoxide 
dismutase 2 initiating activation and reducing ROS production (Bause and Haigis, 
2013). Furthermore, SIRT3 is able to increase NADH concentrations via isocitrate 
dehydrogenase 2 activation, thus promoting the formation of glutathione, which 
reduces mitochondrial ROS (Someya et al., 2010). Previously, highly oxidative 
environments induced by FB1 (200 µM, 24 hr) exposure stimulated the upregulation of 
SIRT3 protein expression in human hepatocellular carcinoma cells (Arumugam et al., 
2019). FB2 showed similar results at the lowest and highest concentrations for both 
protein and gene expression, suggesting that stress responses were upregulated 
(Figure 4.4A and C) in response to the excessive ROS production observed (Figure 
4.3A). Discrepancies in toxicity is noted at the IC50 where a downregulation in SIRT3 
protein and gene expression (Figure 4.4A and C) is observed, which indicates that 
SIRT3-activated stress responses were inhibited. This result is significant in proposing 
that FB2 has the ability to specifically inhibit mitochondrial stress response inducing 
dysfunction in the organelle and promoting cell death. 
Oxidative environments result in damage to proteins. LONP1 is involved in the UPRmt 
and aids in the degradation of oxidatively damaged and misfolded proteins. The 
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inhibition of LONP1 results in the accumulation of damaged proteins that induce toxic 
manifestations within the mitochondria, thus promoting mitophagy. LONP1 is post 
translationally regulated by SIRT3 whereby LONP1 protein expression is decreased 
when SIRT3 is present. However, other cases demonstrate that SIRT3 expression had 
no effect on LONP1 mRNA thus allowing for LONP1 activation in spite of SIRT3 
presence (Gibellini et al., 2014, Bota et al., 2005). Previously exposure to FB1 
significantly upregulated LONP1 as a method to remove oxidised proteins. The 
increase in oxidised proteins was attributed to excessive ROS production caused by 
FB1 (Arumugam et al., 2019). Conversely, treatment with high concentrations of FB2 
prevented activation of this protein. Data obtained for the IC50 showed no significant 
changes in LONP1 indicating that FB2 prevented an upregulation in mitochondrial 
stress response (Figure 4.5B). At the highest concentration, SIRT3 expression is 
elevated, thus causing an inhibition in LONP1 expression (Figure 4.5A and B) in line 
with previous experiments carried out (Gibellini et al., 2014, Bota et al., 2005).  
The inhibition of LONP1 observed indicates that exposure to FB2 allows for the 
accumulation of oxidatively damaged proteins in the matrix which may form 
aggregates and induce mitochondrial toxicity (Ngo et al., 2013). This was prevented 
in the lowest concentration as an upregulation in LONP1 is noted suggesting an 
adequate activation of the UPRmt (Figure 4.5B). The upregulation of LONP1 occurred 
despite SIRT3 activation correlating to the theory that SIRT3 has no effect on LONP1 
mRNA expression (Gibellini et al., 2014, Bota et al., 2005). 
Nrf2 transcribes for various antioxidant genes in response to unwarranted ROS 
production (Ma, 2013). Activation of this transcription factor is phosphorylation-
dependent (Huang et al., 2002). Studies have implicated excessive ROS production 
in the activation of phosphorylation pathways, such as the mitogen activated protein 
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kinase and protein kinase C (Chen et al., 2015). Kinases phosphorylate Nrf2 and 
triggers dissociation from KEAP1. This promotes the translocation of phosphorylated 
(Ser40) Nrf2 to the nucleus, wherein genes are transcribed (Huang et al., 2002). More 
specifically Nrf2 transcriptionally activates PINK1 in response to excessive ROS 
production. Considering PINK1 is a vital protein in the process of mitophagy, Nrf2 is 
proposed as a promoter of the mitophagic process (Murata et al., 2015). Additionally, 
Nrf2 is seen to upregulate p62 protein expression during oxidative stress (Jain et al., 
2010). Previously, exposure to FB1 prompted increases in the expression of 
phosphorylated (Ser40) Nrf2 as a method to reduce oxidative stress (Arumugam et 
al., 2019, Khan et al., 2018). This agrees with data obtained for FB2 (Figure 4.5) 
however, in the present study, the upregulation noted is attributed to promotion of 
mitophagy rather than an antioxidant response. The upregulation in Nrf2 is in line with 
elevated ROS production (Figure 4.3A) and mitochondrial stress noted. Furthermore, 
increases in Nrf2 protein expression occurs when the mitochondrial respiration chain 
is disrupted. This coincides with ATP concentrations measured (Figure 4.2B). 
MiRNA has been implicated in the epigenetic regulation of various biological 
processes (Maltby et al., 2016, Hammond et al., 2001). MiR-27b is a negative 
regulator of mitophagy as it has the potential to directly inhibit PINK1 expression. 
Inhibition is carried out when miR-27b binds to the 3’-UTR of PINK1 mRNA, thus 
preventing its translation. Inactivation of PINK1 results in suppression of downstream 
mitophagic proteins such as p62 (Kim et al., 2016). At higher concentrations of FB2, 
miR-27b is supressed (Figure 4.6D) resulting in increased PINK1 gene and protein 
expression (Figure 4.6A and B). Furthermore, correlating results are seen in p62 
protein expression as PINK1 is known to activate the protein (Figure 4.6C). This 
phenomenon indicates that at high concentrations of FB2, epigenetic regulation of 
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mitophagy occurs. Additionally, the upregulation in PINK1 and p62 coincides with 
significant increases in Nrf2 protein expression (Figure 4.5). The occurrence of 
mitophagy post high concentration FB2 exposure is in agreement with the supressed 
mitochondrial stress responses, increased ROS, increased mitochondrial membrane 
depolarisation and compromised function of the organelle. Furthermore, this suggests 
that FB2 like FB1 induces toxicity via mitochondrial dysregulation. 
A new mechanism is noted at the lower concentration where suppression in 
mitophagic regulators (Figure 4.6A, B and C) are noted regardless of epigenetic 
stimulation of the proteins (Figure 4.6D). Furthermore, FB2 was able to prevent the 
upregulation of PINK1 despite increases in Nrf2 observed (Figure 4.5). The result 
achieved is ascribed to FB2 failing to inhibit complexes in the ETC preventing the need 
for mitophagy. Inhibition of mitophagy is in agreement with the activation of 
mitochondrial stress responses, decreased ROS production, reduced mitochondrial 
membrane depolarisation, maintenance of protein clearance and increased 
proliferation noted. This result has potential consequences in progression of tumour 
formation and cancer as proliferation is promoted at low concentrations of FB2. 
The overall results suggest that at high concentrations of FB2, the functional groups 
are able to act in similar ways as FB1. This possibly results in inhibition of complexes 
within the ETC, which causes mitochondrial dysfunction via exacerbated ROS 
production, derangement in stress responses and ultimately, mitophagy. Lower 
concentrations however, are unable to do so causing a suppression in mitophagic 
proteins and thus promoting proliferation. 
Mitochondrial dysfunction has been reported as the underlying mechanism for various 
kidney disorders (Granata et al., 2009). This study reports that FB2 plays a pivotal role 
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in inducing dysregulation of mitochondrial function in kidney cells, thus altering the 
viability of cells. Additionally, FB2 has been shown to play a role in ROS production. 
Furthermore, the present study introduces a novel concept of epigenetic regulation in 
FB2-induced mitophagy. Despite these findings, further studies need to be carried out 
to determine the role of FB2 in mitochondrial dysregulation and ROS production to 
establish alternative pathways of toxicity. 
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Chapter 6: Limitations and Recommendations 
The current study was a pilot study carried out in an in vitro model following 24 hr 
exposure to varying concentration of FB2. In vitro models generally provide preliminary 
results, while in vivo models provide a more accurate representation of how the toxin 
would behave in the human body. Furthermore, no data exists to show the effects of 
FB2 in humans, thus creating complications in verifying data however, comparisons 
were drawn to effects of the structural analog FB1. 
Future studies should include longer exposure periods in in vivo models to establish 
pathways of toxicity. Due to comparisons between FB1 and FB2, studies should be 
carried out using both toxins to determine the more toxic compound as well as any 
synergistic effects that may arise during exposure. This would be particularly 
interesting as both toxins co-exist in the natural environment increasing the chances 
of concurrent human exposure. 
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Chapter 7: Conclusion 
The present study exhibiting contrasting results for lower and higher concentrations of 
FB2 confirms that the toxin has the ability to selectively promote and inhibit proliferation 
via interference with mitochondrial stress response function. Therefore, it can be 
deduced that FB2 displays biphasic effects (hormesis) characterised by low dose 
stimulation of cell viability and high dose inhibition of cell viability.  
A plethora of mycotoxins have been implicated in the pathogenesis of diseases. It is 
vital to understand the mechanism by which these fungal secondary metabolites work 
to induce toxicity especially in humans. Fumonisins are among the most common 
contaminants of maize however, human studies on the toxic subtype FB2 are 
overlooked and limited knowledge is available on the effect of FB2 on mitochondrial 
function. Low concentrations of FB2 (100 µM) induced mitochondrial stress responses 
therefore maintaining mitochondrial function and preventing mitophagy. This 
prevented cell death and allowed for cell proliferation alluding to the probable 
oncogenic properties of the toxin. High concentrations (317.4 µM and 500µM) of FB2 
supressed mitochondrial stress responses, thus resulting in mitophagy. Furthermore, 
epigenetic regulation of mitophagy was observed.  
 
FB2 contamination of maize is highly prevalent. Coincidentally, a large percentage of 
maize consumers are infected with HIV prompting use of anti-retroviral drugs that 
induce nephrotoxicity. FB2 may potentiate nephrotoxicity due to its polarity. The results 
from this study may provide insights into reducing diet induced nephrotoxicity and may 
contribute to understanding of the implications of FB2 toxicity on the health of 
consumers. 
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Appendix B 
Standard Curve 
 
Figure 1: BCA standard curve used for standardising proteins 
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